Orthovisc

Orthovisc

Orthopedics An injectable hyaluronic acid for treating osteoarthritis of the knee; viscoelastic and lubricating properties are similar to normal synovial fluid. See Hyaluronic acid.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Anika's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, andCINGAL, viscosupplements which alleviate pain and restore joint function by replenishing depleted HA, andHYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration.
Anika's orthopedic medicine portfolio includes Orthovisc, Monovisc, and Cingal, viscosupplements which alleviate pain and restore joint function by replenishing depleted HA, and Hyalofast, a solid HA-based scaffold to aid cartilage repair and regeneration.
Food and Drug Administration in 1997.These injections are sold under various brand names such as Hyalgan, Orthovisc, Synvisc, Gel-One, Supartz, and Euflexxa.
They do contain a small amount of growth factors that can be found in PRP and a small amount of hyaluronic acid, which is found in products such as Synvisc, Monovisc, Orthovisc and Euflexxa.
market to combine triamcinolone hexacetonide, a well-established, FDA-approved steroid utilized to treat inflammation, with Anika's proprietary cross-linked, non-animal-derived hyaluronic acid, which is the active ingredient in the company's global market-leading viscosupplements, ORTHOVISC and MONOVISC.
The current commercialisation agreement allows Anika to supply CINGAL to Pendopharm for sale in the Canadian market, where Pendopharm is Anika's sole commercialisation partner for its ORTHOVISC and MONOVISC products.
Anika's products range from orthopedic/joint health solutions led by Orthovisc and Monovisc, treatments for osteoarthritis of the knee; to surgical aids in the anti- adhesion and ophthalmic fields.
They include steroid shots, which provide short-term relief but may cause joint damage if repeated more than three times a year, and, for knee pain, the joint lubricant hyaluronic acid (Hyalgan, Orthovisc and Synvisc), though it should be tried only if other methods have failed.
Several new products derived from cartilage have been approved for joint injection, including Synvisc, Hyalgan, and Orthovisc. These products are usually injected into the joint space once a month for a total of three months.
has introduced Orthovisc (high-molecular-weight hyaluronan), a new treatment option for patients suffering from pain due to osteoarthritis.